How we approach coagulopathy with vascular anomalies

Pediatr Blood Cancer. 2022 Aug:69 Suppl 3:e29353. doi: 10.1002/pbc.29353.

Abstract

Some vascular anomalies can present with challenging hematologic aberrations. Kaposiform hemangioendothelioma (KHE) may be complicated with Kasabach-Merritt phenomenon (KMP) and stagnant blood flow in slow-flow malformations can promote activation and consumption of coagulation factors, which results in bleeding and clotting known as localized intravascular coagulopathy (LIC). These patients can experience significant morbidity secondary to pain due to thrombosis and are at higher risk of hematologic complications during surgical procedures. No standard of care has been established to prevent or manage these complications. This review focuses on the management of coagulopathy in children and adults with vascular anomalies.

Keywords: bleeding; coagulopathy; thrombosis; vascular anomalies.

Publication types

  • Review

MeSH terms

  • Adult
  • Blood Coagulation Disorders* / etiology
  • Blood Coagulation Disorders* / therapy
  • Child
  • Hemangioendothelioma* / complications
  • Hemangioendothelioma* / therapy
  • Humans
  • Kasabach-Merritt Syndrome*
  • Sarcoma, Kaposi*
  • Vascular Malformations* / complications
  • Vascular Malformations* / therapy